Successfully protecting and promoting geographical indications (GIs) – best practices were shared by important institutions and representatives of various GIs from Europe and Latin America at a webinar hosted by IP Key LA.
[...]
On 16 March, the EUIPO held a meeting to introduce the SME initiatives to the
[...]
IP Key LA, the Mexican Institute of Industrial Property and the EU Delegation in Mexico have presented the first IP Economic Impact Study in Latin America. This study focuses on the Mexican economy and is the result of a long and detailed investigation carried out over several months.
[...]
IP Key LA and the Mexican Institute of Industrial Property (IMPI) are proud to announce the presentation of the first IP Economic Impact Study in Latin America.
[...]
The European Union protects more than three thousand names of agricultural products and foodstuffs, fisheries and aquaculture, wines, spirit drinks and aromatised wine products, under one of its EU quality schemes: Geographical Indication (GI), Prote
[...]
IP Key Latin America (LA) is an EU project directed and funded by the European Commission and implemented by the European Union Intellectual Property Office. It started in 1 September 2017 with a duration of 4 years.
[...]
From 14 to 18 December 2020, experts from the Andean Community and the European Union participated online in the third edition of the IP Enforcement and Governance Week, organised by IP Key LA.
[...]
The Federation of Industries of the State of São Paulo (FIESP), INPI Brazil, and IP Key LA co-hosted the virtual seminar Blockchain and Intellectual Property: Protection, traceability of products and combating counterfeit.
[...]
In the countries of the European Union and Latin America, SMEs account for 99 % of all businesses. They are a key element of both economies.
[...]
In the context of a global pandemic, and with the aim of providing valuable information on the importance of intellectual property (IP) in the pharmaceutical industry, IP Key LA held an online event focused on the fight against counterfeit medicines on the basis of IP rights, highlighting the dan
[...]